[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100518184":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":29,"centralContacts":33,"locations":40,"responsibleParty":56,"collaborators":25,"id":59,"slug":60,"hasResults":61,"nctId":62,"briefTitle":63,"officialTitle":63,"acronym":25,"eligibilityCriteria":64,"healthyVolunteers":61,"sex":65,"minAge":66,"maxAge":25,"enrollmentInfo":67,"targetDuration":25,"studyType":70,"phases":71,"briefSummary":73,"conditions":74,"keywords":78,"overallStatus":42,"whyStopped":25,"lastUpdateSubmitDate":82,"lastUpdatePostDateStruct":83,"startDateStruct":86,"completionDateStruct":88,"leadSponsor":90,"locationsCount":91},{"fullName":5,"class":6},"National Taiwan University Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Without oral glutamine supplementation","PLACEBO_COMPARATOR","15 g Maltodextrin for 28 days after surgery with tolerable oral intake or enteral feeding",[13],"Dietary Supplement: Maltodextrin",{"label":15,"type":16,"description":17,"interventionNames":18},"With oral glutamine supplementation","ACTIVE_COMPARATOR","10 g glutamine +5 g Maltodextrin for 28 days after surgery with tolerable oral intake or enteral feeding",[19,13],"Dietary Supplement: oral glutamine",[21,26],{"type":22,"name":23,"description":17,"armGroupLabels":24,"otherNames":25},"DIETARY_SUPPLEMENT","oral glutamine",[15],null,{"type":22,"name":27,"description":27,"armGroupLabels":28,"otherNames":25},"Maltodextrin",[15,9],[30],{"name":31,"affiliation":5,"role":32},"Jin-Ming Wu, MD","PRINCIPAL_INVESTIGATOR",[34,38],{"name":31,"role":35,"phone":36,"phoneExt":25,"email":37},"CONTACT","886+223123456","wujm0531@gmail.com",{"name":39,"role":35,"phone":25,"phoneExt":25,"email":37},"Ming-Tsan Lin, MD",[41],{"facility":5,"status":42,"city":43,"state":25,"zip":44,"country":45,"countryCode":46,"cosmosGeoPoint":47,"geoPoint":52,"contacts":53},"RECRUITING","Taipei","100","Taiwan","TW",{"type":48,"coordinates":49},"Point",[50,51],121.52639,25.05306,{"lat":51,"lon":50},[54],{"name":31,"role":35,"phone":55,"phoneExt":25,"email":37},"886-223123456",{"type":32,"investigatorFullName":57,"investigatorTitle":58,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"National Taiwan University Clinical Trial Center","Jin-Ming Wu, Clinical Associate Professor & PhD","100518184","oral-supplementation-of-glutamine-on-gastric-cancer-patients-after-gastrectomy-100518184",false,"NCT06027242","Oral Supplementation of Glutamine on Gastric Cancer Patients After Gastrectomy","Inclusion Criteria:\n\n* adult gastric cancer receiving gastrectomy\n\nExclusion Criteria:\n\n* Hepatic insufficiency\n* Renal insufficiency\n* can not tolerate oral or enteral feeding 7 days after gastrectomy\n* can not receive computed tomograph\n* can not waer the wearable devices","ALL","20 Years",{"count":68,"type":69},120,"ESTIMATED","INTERVENTIONAL",[72],"NA","Glutamine has the potentials of immunomodulation and adjustment of protein metabolism. The primary objective of this study is to evaluate the efficacy of glutamine on sarcopenia in gastric adenocarcinoma patients undergoing gastrectomy. The secondary endpoints, including the physical activity, weight loss, and nutritional profiles, will be evaluated among these patients.",[75,76,77],"Gastric Cancer","Immunonutrition","Gastrostomy",[79,80,81],"Gastric cancer","Gastrectomy","sarcopenia","2025-12-16",{"date":84,"type":85},"2025-12-23","ACTUAL",{"date":87,"type":85},"2023-02-21",{"date":89,"type":69},"2026-08-30",{"name":5,"class":6},1]